1. Ashrafian H, Zadeh EH, Khan RH. Review on Alzheimer's disease: inhibition of amyloid beta and tau tangle formation. International journal of biological macromolecules. 2021;167:382-94. [DOI:10.1016/j.ijbiomac.2020.11.192]

2. Breijyeh Z, Karaman R. Comprehensive review on Alzheimer's disease: causes and treatment. Molecules. 2020;25(24):5789. [DOI:10.3390/molecules25245789]

3. Giuffrida ML, Copani A, Rizzarelli E. A promising connection between BDNF and Alzheimer's disease. Aging (Albany NY). 2018;10(8):1791. [DOI:10.18632/aging.101518]

4. Mitra S, Behbahani H, Eriksdotter M. Innovative therapy for Alzheimer's disease-with focus on biodelivery of NGF. Frontiers in neuroscience. 2019;13:434303. [DOI:10.3389/fnins.2019.00038]

5. Croce N, Gelfo F, Ciotti MT, Federici G, Caltagirone C, Bernardini S, et al. NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection? Molecular and cellular biochemistry. 2013;376:189-95. [DOI:10.1007/s11010-013-1567-0]

6. Abdolahi S, Zare-Chahoki A, Noorbakhsh F, Gorji A. A review of molecular interplay between neurotrophins and miRNAs in neuropsychological disorders. Molecular neurobiology. 2022;59(10):6260-80. [DOI:10.1007/s12035-022-02966-5]

7. Castrén E. Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection. Molecular neurobiology. 2004;29:289-301. [DOI:10.1385/MN:29:3:289]

8. Nordvall G, Forsell P, Sandin J. Neurotrophin-targeted therapeutics: A gateway to cognition and more? Drug discovery today. 2022;27(10):103318. [DOI:10.1016/j.drudis.2022.07.003]

9. Voss MW, Nagamatsu LS, Liu-Ambrose T, Kramer AF. Exercise, brain, and cognition across the life span. Journal of applied physiology. 2011;111(5):1505-13. [DOI:10.1152/japplphysiol.00210.2011]

10. Erickson KI, Leckie RL, Weinstein AM. Physical activity, fitness, and gray matter volume. Neurobiology of aging. 2014;35:S20-S8.

11. Jafarzadeh G, Shakerian S, Farbood Y, Ghanbarzadeh M. Effects of eight weeks of resistance exercises on neurotrophins and trk receptors in alzheimer model male wistar rats. Basic and Clinical Neuroscience. 2021;12(3):349. [DOI:10.32598/bcn.2021.2067.1]

12. Özbeyli D, Çakır ÖK. The effects of different exercise modalities in Alzheimer's disease. Clinical and Experimental Health Sciences. 2017;7(1):27-31. [DOI:10.5152/clinexphealthsci.2017.230]

13. Stein AM, Coelho FGdM, Vital-Silva TM, Rueda AV, Pereira JR, Deslandes AC, et al. Aerobic training and circulating neurotrophins in alzheimer's disease patients: A controlled trial. Experimental Aging Research. 2023;49(1):1-17. [DOI:10.1080/0361073X.2022.2048586]

14. Mueed Z, Tandon P, Maurya SK, Deval R, Kamal MA, Poddar NK. Tau and mTOR: the hotspots for multifarious diseases in Alzheimer's development. Frontiers in neuroscience. 2019;12:1017. [DOI:10.3389/fnins.2018.01017]

15. Cicero AF, Ruscica M, Banach M. Resveratrol and cognitive decline: a clinician perspective. Archives of Medical Science. 2019;15(4):936-43. [DOI:10.5114/aoms.2019.85463]

16. Labban S, Alghamdi BS, Alshehri FS, Kurdi M. Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer's disease. Behavioural Brain Research. 2021;402:113100. [DOI:10.1016/j.bbr.2020.113100]

17. Serra MP, Boi M, Poddighe L, Melis T, Lai Y, Carta G, et al. Resveratrol regulates BDNF, trkB, PSA-NCAM, and Arc expression in the rat cerebral cortex after bilateral common carotid artery occlusion and reperfusion. Nutrients. 2019;11(5):1000. [DOI:10.3390/nu11051000]

18. Tang X, Zhao Y, Zhou Z, Yan J, Zhou B, Chi X, et al. Resveratrol mitigates sevoflurane-induced neurotoxicity by the SIRT1-dependent regulation of BDNF expression in developing mice. Oxidative medicine and cellular longevity. 2020;2020. [DOI:10.1155/2020/9018624]

19. Park HR, Kong KH, Yu BP, Mattson MP, Lee J. Resveratrol inhibits the proliferation of neural progenitor cells and hippocampal neurogenesis. Journal of Biological Chemistry. 2012;287(51):42588-600. [DOI:10.1074/jbc.M112.406413]

20. Eslimiesfahani D, Oryan S, Khosravi M, Valizadegan F. Effect of fennel extract on the improvement of memory disorders in beta amyloid alzheimer model of male wistar rats. 2019. [DOI:10.29252/sjimu.27.1.1]

21. Wu C, Yang L, Li Y, Dong Y, Yang B, Tucker LD, et al. Effects of exercise training on anxious-depressive-like behavior in Alzheimer rat. Medicine and science in sports and exercise. 2020;52(7):1456. [DOI:10.1249/MSS.0000000000002294]

22. Monserrat Hernández‐Hernández E, Serrano‐García C, Antonio Vázquez‐Roque R, Díaz A, Monroy E, Rodríguez‐Moreno A, et al. Chronic administration of resveratrol prevents morphological changes in prefrontal cortex and hippocampus of aged rats. Synapse. 2016;70(5):206-17. [DOI:10.1002/syn.21888]

23. Moghadasi M, Akbari F, Najafi P. Interaction of aerobic exercise and crocin improves memory, learning and hypocampic tau and neurotrophins gene expression in rats treated with trimethytin as a model of Alzheimer's disease. Molecular biology reports. 2024;51(1):111. [DOI:10.1007/s11033-023-09197-4]

24. Lee YI, Kim YG, Pyeon HJ, Ahn JC, Logan S, Orock A, et al. Dysregulation of the SNARE-binding protein Munc18-1 impairs BDNF secretion and synaptic neurotransmission: a novel interventional target to protect the aging brain. Geroscience. 2019;41:109-23. [DOI:10.1007/s11357-019-00067-1]

25. Eremenko E, Mittal K, Berner O, Kamenetsky N, Nemirovsky A, Elyahu Y, et al. BDNF-producing, amyloid β-specific CD4 T cells as targeted drug-delivery vehicles in Alzheimer's disease. EBioMedicine. 2019;43:424-34. [DOI:10.1016/j.ebiom.2019.04.019]

26. Fonseca-Gomes J, Jerónimo-Santos A, Lesnikova A, Casarotto P, Castrén E, Sebastião AM, et al. TrkB-ICD fragment, originating from BDNF receptor cleavage, is translocated to cell nucleus and phosphorylates nuclear and axonal proteins. Frontiers in Molecular Neuroscience. 2019;12:4. [DOI:10.3389/fnmol.2019.00004]

27. Huang H, Li W, Qin Z, Shen H, Li X, Wang W. Physical exercise increases peripheral brain-derived neurotrophic factors in patients with cognitive impairment: A meta-analysis. Restorative Neurology and Neuroscience. 2021;39(3):159-71 [DOI:10.3233/RNN-201060]

28. Belviranlı M, Okudan N. Voluntary, involuntary and forced exercises almost equally reverse behavioral impairment by regulating hippocampal neurotrophic factors and oxidative stress in experimental Alzheimer's disease model. Behavioural Brain Research. 2019 May 17;364:245-55. [DOI:10.1016/j.bbr.2019.02.030]

29. Vafaei AA, Jezek K, Bures J, Fenton AA, Rashidy-Pour A. Post-training reversible inactivation of the rat's basolateral amygdala interferes with hippocampus-dependent place avoidance memory in a time-dependent manner. Neurobiology of learning and memory. 2007;88(1):87-93. [DOI:10.1016/j.nlm.2007.02.004]

30. Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends in neurosciences. 2002;25(6):295-301. [DOI:10.1016/S0166-2236(02)02143-4]

31. Bariohay B, Lebrun B, Moyse E, Jean A. Brain-derived neurotrophic factor plays a role as an anorexigenic factor in the dorsal vagal complex. Endocrinology. 2005;146(12):5612-20. [DOI:10.1210/en.2005-0419]

32. Broderick TL, Rasool S, Li R, Zhang Y, Anderson M, Al-Nakkash L, et al. Neuroprotective effects of chronic resveratrol treatment and exercise training in the 3xTg-AD mouse model of Alzheimer's disease. International journal of molecular sciences. 2020;21(19):7337. [DOI:10.3390/ijms21197337]

33. D Rege S, Geetha T, L Broderick T, Ramesh Babu J. Resveratrol protects β amyloid-induced oxidative damage and memory associated proteins in H19-7 hippocampal neuronal cells. Current Alzheimer Research. 2015;12(2):147-56. [DOI:10.2174/1567205012666150204130009]

34. Pallas M, Ortuno-Sahagun D, Benito-Andres P, Ponce-Regalado MD, Rojas-Mayorquin AE. Resveratrol in epilepsy: preventive or treatment opportunities. Front Biosci. 2014;19:1057-64. [DOI:10.2741/4267]

35. Saleh MC, Connell BJ, Saleh TM. Resveratrol induced neuroprotection is mediated via both estrogen receptor subtypes, ERα and ERβ. Neuroscience Letters. 2013;548:217-21. [DOI:10.1016/j.neulet.2013.05.057]

36. Yang AJ, Bagit A, MacPherson RE. Resveratrol, metabolic dysregulation, and Alzheimer's disease: Considerations for neurogenerative disease. International journal of molecular sciences. 2021;22(9):4628. [DOI:10.3390/ijms22094628]

37. Ghoweba RE, Khowailed AA, Aboulhoda BE, Rashed LA, Selmy A. Synergistic role of resveratrol and exercise training in management of diabetic neuropathy and myopathy via SIRT1/NGF/GAP43 linkage. Tissue and Cell. 2023;81:102014. [DOI:10.1016/j.tice.2023.102014]